Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer – Authors' reply
Research output: Contribution to journal › Comment/debate › Research
Original language | English |
---|---|
Journal | The Lancet Oncology |
Volume | 21 |
Issue number | 11 |
Pages (from-to) | e516 |
Number of pages | 1 |
ISSN | 1470-2045 |
DOIs |
|
Publication status | Published - 1 Nov 2020 |
ID: 260747382